Status: Recruiting
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
The main objective of this project is to identify a new non-invasive biological test for the diagnosis of LPS by measuring circulating serine levels. The current gold standard is the detection of Mdm2 amplification by the FISH.
Participants needed: 158
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Institut du Cancer de Montpellier - Val d'AurelleUpdated: Feb 12, 2025Locations: 1
Eligibility criteria
Localized WD-LPS and DD-LPS, and/or [+3]